Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company carries out wholesale trade in pharmaceutical goods. Registered April 2017; 100% owner Nadezhda Zhornik; engaged in pharmaceutical distribution.
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|
| Total Revenue | 2,385 | 2,416 | 2,980 | 3,488 | 2,960 | +5.6% |
| Total COGS | 1,255 | 1,150 | 1,498 | 1,657 | 1,348 | +1.8% |
| Gross Profit | 1,130 | 1,267 | 1,482 | 1,830 | 1,612 | +9.3% |
| Gross Margin | 47.4% | 52.4% | 49.7% | 52.5% | 54.5% | |
| 596 | 839 | 473 | 529 | 594 | -0.1% | |
| EBITDA | 534 | 428 | 1,009 | 1,301 | 1,018 | +17.5% |
| EBITDA Margin | 22.4% | 17.7% | 33.9% | 37.3% | 34.4% | |
| Total D&A | 11 | 7 | 8 | 9 | 5 | -16.1% |
| EBIT / Operating Income | 523 | 421 | 1,001 | 1,292 | 1,013 | +18.0% |
| Total Interest Income | 0 | 0 | 0 | 8 | 11 | +30.4% |
| Total Other Income | 4 | 58 | 76 | 66 | 89 | +123.5% |
| Profit Before Tax | 526 | 479 | 1,077 | 1,367 | 1,112 | +20.6% |
| Total Income Tax | 13 | 24 | 73 | 68 | 254 | +111.8% |
| Net Profit / (Loss) | 514 | 455 | 1,004 | 1,298 | 858 | +13.7% |
| Net Margin | 21.5% | 18.8% | 33.7% | 37.2% | 29.0% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →